Radiant Pain Relief Centres is changing the way chronic pain is understood and treated, providing lasting relief without drugs, needles, surgery or side effects.
In the US, over 100 million people suffer with chronic pain - this is more than the number of people with cancer, diabetes and cardiovascular disease combined, and similar numbers exist throughout the world. The opioid addiction epidemic makes this enormous problem very urgent, but it also underscores the limitations and lack of effective treatment options available for chronic pain management.
It is time for better safer solution, and this is your opportunity to be a part of it. We’re raising up to $3M in private capital to invest in marketing, business development, as well as begin the process of new technology development.
Radiant’s novel direct-to-consumer business has all the markers of industry disruption backed by several years of clinical and business proof, FDA-clearance and research from institutions such as Mayo Clinic and Johns Hopkins. A highly refined care model, built around technology and a business model that creates economic sensibilities throughout the supply chain:
•For consumers: it is affordable and invaluable to get lasting relief without drugs, needles, surgery or side effects, yet a strong average sale price and 40%+ gross margins allow for high profit potential
•For clinicians: a “reverse franchise” model, gives clinicians an attractive, flexible and passive investment opportunity, while allowing the company to expand rapidly with minimal capital outlay
•Investors/shareholders: a deeply discounted, pre-RegA+ public, investment opportunity with multiple return paths, (equity increase and quarterly dividend distributions), multiple liquidity paths (acquisition, public uplisting), and a highly impactful “social-good” investment
Modern Scientific Understanding of Pain:
A better solution starts with modern science. The scientific understanding of pain and chronic pain has changed significantly in recent years. Unfortunately most clinicians are trained in pain science from the 1960s, they lag behind in understanding and commonly continue to promote therapies like those listed above because of a lack of understanding and because of economics tied to those treatments. But modern pain science makes clear that the pain is a phenomenon of the brain, not the tissue. It is generated in the brain and experienced in the tissue. In the short term, acute phase, pain is protective and productive, alerting the sufferer of a problem. Chronic pain however is no longer protective or productive. When pain becomes chronic, the brain becomes wired to expect and perpetuate that pain experience in a way that is inappropriate and it does so, often, regardless of what is happening in the tissue. We feel it in the tissue, we think it is a tissue problem, but addressing it there is not effective because it's really a brain problem. To better understand this, think of phantom pain. Essentially all chronic pain is “phantom pain”.
Strong Competitive Therapeutic and Market Differentiation:
Understanding this, Radiant uses novel therapies, specifically an FDA-cleared technology which has been researched at the Mayo Clinic and Johns Hopkins, which allows us to retrain the brain using artificial nerve impulses and neuroplasticity (the brain’s ability to learn). Our therapy is totally non-invasive, safe, consistently effective and appealing. Through it we can achieve significant relief, which becomes lasting for nearly all types of chronic pain, without drugs, needles, surgery or side effects. It is life changing and life saving.
Rather than selling devices into a broken and fragmented medical system, we’re building centers around this technology. These centers allow us to create a higher level of customer experience and efficiency in the business and clinical delivery of the therapy, which makes it affordable, without dependency on insurance coverage, and highly profitable to the company. This also allows us to create consistency necessary to build a strong brand and a scalable business. An analogue is Starbucks. Starbucks fundamentally shifted society, changed the way we experience, consume and what we pay for coffee. They did it not by selling a better coffee product to the local diner, they did it by building stores and creating an experience around the coffee. We aim to do the same thing as we work to educate, to shift society and completely change the way we understand and treat chronic pain though our center and care experience.
Clinical and Social Proof:
Radiant founders, P. Brendon Lundberg, MBA, and Harvard/MIT trained physician David Farley, MD, wrote a book, Radiant Relief, A Case For A Better Solution To Chronic Pain, which explains their vision to change the way chronic pain is understood and treated. The book became an Amazon Best Seller, and Inc. Magazine called it a “manifesto” and “an epic example of how to create a movement”. To join the movement, for full investment details, and moving client testimonials, visit www.radiantpainrelief.com/rega